Serum irisin level is higher in peritoneal dialysis than in hemodialysis
- PMID: 36527594
- DOI: 10.1007/s11255-022-03440-w
Serum irisin level is higher in peritoneal dialysis than in hemodialysis
Abstract
Background: Previous studies have proved that irisin is related to the development of chronic kidney disease. In this study, we aimed to compare serum irisin level in patients treated with peritoneal dialysis (PD) and hemodialysis (HD).
Methods: Two hundred and fifty-two dialysis patients (146 PD patients and 106 HD patients) were included in the study. Levels of serum irisin and other parameters were compared between the two groups' patients.
Results: There were higher serum irisin levels in PD patients than those in HD patients [113.10 (106.15 ~ 119.15) ng/ml vs. 45.72(21.67 ~ 79.71) ng/ml, P < 0.001]. Moreover, body fat mass, percent body fat, serum calcium, high-density lipoprotein, low-density lipoprotein, carbon dioxide combining power (CO2CP) and residual renal function were higher in patients on PD than that in those on HD, whereas levels of lean body mass, systolic blood pressure, albumin, serum uric acid, potassium, and phosphorus(It should be "were" replace are) are higher in HD patients in comparison to PD patients. Dialysis modality (PD/HD), serum CO2CP level, lean body mass, and percent body fat independently positively correlated with natural logarithm of irisin (lnirisin) by multivariate linear regression analysis.
Conclusions: In this study, we prove that serum irisin level is significantly higher in patients treated with peritoneal dialysis than that with hemodialysis. As well as, increasing skeletal muscle mass and fat body percent, and correcting metabolic acidosis may increase serum irisin levels.
Keywords: Chronic kidney disease; Hemodialysis; Irisin; Peritoneal dialysis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Hoppe K, Schwermer K, Kawka A, Klysz P, Baum E, Kaluzna M, Sikorska D, Scigacz A, Lindholm B, Pawlaczyk K, Oko A (2018) Dialysis vintage stratified comparison of body composition, hydration and nutritional state in peritoneal dialysis and hemodialysis patients. Arch Med Sci 14(4):807–817. https://doi.org/10.5114/aoms.2016.61902 - DOI - PubMed
-
- Vanholder R, Van Laecke S, Glorieux G (2008) The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol 21(2):146–160 - PubMed
-
- Gan W, Chen W, Li T, Shao D, Xu F, Huo S, Li C, Yang Z, Zeng X (2022) Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis. Int Urol Nephrol 54(6):1295–1302. https://doi.org/10.1007/s11255-021-03000-8 - DOI - PubMed
-
- Gouveia MC, Vella JP, Cafeo FR, Affonso Fonseca FL, Bacci MR (2016) Association between irisin and major chronic diseases: a review. Eur Rev Med Pharmacol Sci 20(19):4072–4077 - PubMed
-
- Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belén Crujeiras A, Seoane LM, Casanueva FF, Pardo M (2013) FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 8(4):e60563. https://doi.org/10.1371/journal.pone.0060563 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
